Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAGNET in Amyotrophic Lateral Sclerosis (ALS)
NCT06008249Phase 3Terminated
- Sponsor
- TRICALS
- Start
- Aug 2021
- Primary completion
- Sep 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 6
01
Overview
A Phase 3 trial of lithium carbonate in amyotrophic lateral sclerosis (ALS), sponsored by TRICALS. Started Aug 2021; status: terminated.
02
Drugs
lithium carbonate
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT06008249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06008249.